S
Sidewinder Therapeutics
Biotech & Life Sciences · San Diego, United States · Founded 2023
Precision biologics targeting molecular drivers of cancer and rare diseases MoreLess
Sidewinder Therapeutics is a biotechnology company dedicated to developing precision biologics aimed at treating cancer and rare diseases. The company operates in the therapeutics market, focusing on large molecule drugs that target specific molecular drivers of disease. Sidewinder's business model revolves around drug discovery and development, leveraging the expertise of a dynamic team of serial entrepreneurs and expert scientists. Revenue is generated through the advancement and commercialization of innovative medicines designed to improve patient outcomes. The company serves patients with unmet medical needs, particularly those suffering from complex conditions that require targeted therapeutic interventions. Sidewinder's commitment to delivering life-saving therapies is underscored by its leadership team's extensive experience in the field. Keywords: precision biologics, cancer, rare diseases, drug discovery, large molecule, molecular drivers, therapeutics, patient outcomes, biotechnology, drug development.
Company overview
Sidewinder Therapeutics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2023
- Headquarters
- San Diego, United States
- Employees
- 9
- Open positions
- None listed
- Dealroom signal
- 64.3
Valuation & funding
Sidewinder Therapeutics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Apr 2026 | $137M | $548M | Longwood Fund · Astellas Venture · Alexandria Venture Investments · Goldman Sachs Asset Management | ↗ |
| SERIES AOther financing | Feb 2023 | $25M | $100M | OrbiMed | ↗ |
Growth signals
Sidewinder Therapeutics website traffic
Latest recorded traffic for Sidewinder Therapeutics is 2.9K monthly website visits, down 6.5% over the last three months. Sidewinder Therapeutics's team grew 12.5% over the past year.
Comparisons
Sidewinder Therapeutics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 Punozhi Pharmaceutical BiotechnologyAI-powered drug discovery for hard-to-drug targets |
China | Operational | — | — | — |
 Biologics4UAI-powered platforms for antibody and ADC drug discovery |
Seoul, South Korea | Operational | |||
 Shizhiyuan BiotechnologyInnovative monoclonal antibody drug development and manufacturing |
China | Operational | |||
 ExonicAI-native platform for biological molecule drug discovery |
San Francisco, United States | Operational | |||
 Neologics BioscienceClinical-stage immuno-modulating antibody therapeutics for cancer |
Changzhou, China | Operational | |||
 Tres AlchemixAI-powered drug discovery platform using quantum chemical calculations |
Fukuoka, Japan | Operational | |||
 Ridge BiotechnologiesAI-enabled platform for precision enzyme and drug design |
Palo Alto, United States | Operational | |||
 Adcoris BioPharmaNext-generation antibody-drug conjugates for oncology |
China | Operational |
Talent graph
Sidewinder Therapeutics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Sidewinder Therapeutics has talent and traffic
team presence
In the news
Latest news about Sidewinder Therapeutics
Recent press, funding announcements, and product moves mentioning Sidewinder Therapeutics — open to read from the original sources.
Market sentiment
What the market is saying about Sidewinder Therapeutics
An AI-synthesized read of the highest-engagement posts about Sidewinder Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sidewinder Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.